Small Cap Feast

Small Cap Feast – 01 October 2019

Dish of the Day:

No Joiners Today

Off the Menu:

No Leavers Today

What’s Cooking in the IPO Kitchen?

Main Market Standard, the largest Payments, Marketplace and Fintech Ecosystem in Kazakhstan with a leading market share in each of its key products and services. GDR offering expected Oct 2019. In the first half of 2019, the Company generated total revenue of KZT226,862m (U.S. $598m), up 34% and net income of KZT77,001m (U.S. $203m), up 54%
Main Market premium
Registration document approved for Helios Towers. The Group provides essential network services, flexible infrastructure solutions and reliable power supply to mobile network operators in five African growth economies. Revenue increased 7 per cent. year-on-year to US$191m (H1 2018: US$178m), with Adjusted EBITDA up 15 per cent. year-on-year at US$99m (H1 2018: US$86m) for the six months ended 30 June 2019.

Breakfast Buffet

Thor Mining* (THOR.L) 0.58p £4.8m

FY Jun 19 results yesterday afternoon.
Op Highlights: Tungsten: Upgraded Definitive Feasibility Study (DFS) for the Molyhil tungsten/ molybdenum project. Acquisition of a 40% interest in the nearby Bonya deposits, which were subsequently drilled with successful outcomes. Scoping Study for the Pilot Mountain tungsten project in Nevada in the United States was released in September 2018, indicating the potential for profitable operations for up to 12 years. Notes that Tungsten price is showing signs of recovery.
Copper: EnviroCopper (Thor 25%) – Successful in securing an Australian Government grant of A$2.85m towards the costs of demonstrating an ISR process at Kapunda. (In -Situ recovery). Post year end EnviroCopper Limited announced an initial resource estimate containing copper, at Moonta, adding to the existing resource estimate for Kapunda.
The Group incurred a loss after taxation of £735,000 (2018 loss: £1,249,000).
Year end cash of £523,000 (2018: £1,374,000).

Infrastrata (INFA.L) 0.42p £6.3m

The UK quoted company focused on strategic infrastructure projects, is pleased to announce that it has signed heads of terms to purchase the principal assets of Harland and Wolff Heavy Industries Limited and Harland and Wolff Group Plc from administrator BDO NI for a total consideration of £6m.
The Assets comprise of a m u l t i – p u r p o s e fabrication facility, quaysides and docking facilities in the port of Belfast, Northern Ireland, ideally suited for the energy infrastructure industry and the Company’s projects.

MXC Capital (MXCP.L) 102.5p £68.9m

“The technology focused adviser and investor, is pleased to announce that it has made a £4.9m investment into Channel Islands Media Group Limited (“CIMG”), its newly established joint venture with the Bailiwick Investment Limited (the “BIL”), a specialist fund which is administered and managed by Ravenscroft Limited, with whom MXC has an existing partnership.

The Investment has enabled CIMG to complete the acquisition of The Guernsey Press Company Limited and its wholly owned subsidiary, Guernsey Distribution Limited (together, “The Guernsey Press”) (the “Acquisition”).

The Guernsey Press is a key source of news and information across the Bailiwick of Guernsey, offering multi-media platforms such as the website and app “GY4U”, as well as the production and distribution of the local newspaper and the wholesale and distribution of national newspapers and magazines. Using technology, the intention is to enhance the content and market share of both the website and app and to provide a full managed service for the digital needs of the Guernsey business community.

B r e e d o n G r o u p (BREE.L) 65.3p £1.1bn

The construction materials group in Great Britain and Ireland, has today acquired Roadway Civil Engineering & Surfacing Ltd (“Roadway”), an integrated asphalt production and contract surfacing business in North Wales, for a total consideration of up to £13.5m.

Roadway is a family-run business based in Llay near Wrexham. Founded in 2000, it specialises in local a u t h o r i t y t e r m maintenance, minor road maintenance schemes and associated civil engineering works. The purchase of the business coincides with the opening of a new asphalt plant on its Wrexham site. Key management will remain with the business.

The total consideration, subject to completion adjustments, comprises £10.8m payable in cash on completion, together with up to £2.7m of deferred consideration payable in cash on performance over the next five years. In the year to 31 July 2018 – p r i o r t o t h e introduction of its new asphalt production capability – Roadway reported underlying EBITDA of £1.3m and profit before tax of £1.3m on revenues of £5.1m.

GAN (GAN.L) 77.6p £66.12m

The award-winning developer and supplier of enterprise-level B2B Internet gambling software, services and online gaming content in the United States, today announced the release of quarterly key performance indicator s (Q3). Gross Operator Revenue, , increased 202.7% yearo v e r – y e a r and 47.3% quarter-over – q u a r t e r t o $80.9m. This change was driven by strong growth in real money regulated gambling in the US.
· Active Player-Days at 5.4m is an increase of 59% year-over-year and increase of 13.5% quarter over quarter.

Share (SHRE.L)30p £43.1m

Co mpl et io n of p r e v i o u s l y announced acquisition of an active book of accounts from J.P. M o r g a n A s s e t Management.
Successful transfer of these accounts, with over 13,000 accounts being on boarded with The Share Centre over the weekend. The accounts hold a range of J.P. Morgan Investment Trusts and/or OEICs and following the migration, customers are able to invest in a wide range of investment vehicles through the platform

Manolete Partners (MANO.L) 485p £211m

“The leading UK-listed insolvency litigation f i n a n c i n g company, announces that Patrick Lineen has decided to retire at the end of December 2019, following the successful IPO of the Company last year. Patrick will step down as Chief Financial Officer on 7 October 2019 when he will be replaced as CFO by Mark W r e n f o r d Tavener. Patrick will remain on the Board until 27 November 2019 and will then retire at the end of the year to ensure an orderly and smooth handover.
Mr Tavener previously worked in RSM’s corporate finance department. Prior to RSM, Mr Tavener held roles at IPSX, Deloitte, T-Mobile and PwC.”

Amryt P h a r m a (AMYT.L) 130p £209m

The biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases, today announces that the U.S. Food and Drug Administration (FDA) has d e s i g n a t e d t h e investigation of AP101 (Oleogel-S10)  for the t r e a t m e n t o f Epidermolysis Bullosa (EB) as a Fast Track d e v e l o p m e n t program.  The FDA has recognised that EB is a serious disease, and that there are no FDA-approved treatments for this condition.  Additionally, the FDA has noted that Amryt has generated preliminary clinical data from an ongoing Phase 3 trial, which supports continued study.

Anglo Asian Mining (AAZ.L) 140.5p £161m

The gold, copper and silver producer focused in Azerbaijan, announced that representatives of the British Embassy in Azerbaijan recently visited the Company’s Gedabek gold, copper and silver mine. A presentation was made to the recently appointed British Ambassador to Azerbaijan, Mr. James Sharp.

Maintel (MAI.L) 421p £60m

Ioan MacRae, aged 46, will be joining the Company as Chief Executive Officer on 14 October 2019.
P r i o r t o t h i s appointment, Ioan was Managing Director for the UK and Ireland of Avaya, a global leader in communications and has held a number of senior leadership positions in the industry both within the UK and internationally. He has considerable experience in leading businesses through

Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.